Publications

Meledathu S, Kurowski A, Naidu MP, Adalsteinsson J, Meehan SA, Alkon N, Port LR, Chennareddy S, Cohenour ER, Christensen G, Shulman J, Gulati N, Jonak C, Brunner PM.

scRNA-Seq reveals anti-lymphoma immune responses in mogamulizumab-associated skin eruptions

J Eur Acad Dermatol Venereol. 2025 Nov

DOI: 10.1111/jdv.70154

Simpson EL, Silverberg JI, Geng B, Carrascosa JM, Bieber T, Brunner PM, Staumont-Sallé D, Ji C, Biswas P, Feeney C, Hernández-Martín I, Rebollo Laserna FJ, Koppensteiner H.

Do Allergic Comorbidities Alter the Efficacy and Safety of Abrocitinib or Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis

Dermatol Ther (Heidelb). 2025 Nov

DOI: 10.1007/s13555-025-01516-w

Liu T, Brunner PM, Marushchak O, Dobrowolski C, Salib C, Magro C.

Methotrexate-Associated Primary Cutaneous Epstein-Barr Virus-Positive Polymorphic B-Cell Lymphoproliferative Disorder With Metachronous T-Cell Clonally Related Angioimmunoblastic T-Cell Lymphoma: A Case Report and Review of the Literature

Am J Dermatopathol. 2025 Nov

DOI: 10.1097/DAD.0000000000003116

Brunner PM.

The landscape of disease: mapping aplastic anemia.

Blood. 2025 Aug

DOI: 10.1182/blood.2025029791

Aleman A, Van Oekelen O, Melnekoff DT, Grossman L, Mouhieddine TH, Kurowski A, Odak I, Reci S, Desai S, Meledathu S, Naidu MP, Shukla RP, Dutta RP, Kappes K, Serebryakova K, Jackson H, Lu J, Chatikhine A, Kulkarni R, Moinfar Z, Croken MM, Mehrotra M, Baskovich B, Rayamajhi S, Richard S, Rossi AC, Salib C, Houldsworth J, Brown BD, Merad M, Laganà A, Brunner PM, Jagannath S, Brody JD, Parekh S.

Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy

N Engl J Med. 2025 Aug

DOI: 10.1056/NEJMc2504588

Brunner PM, David E, Del Duca E, Manson M, Kurowski A, Naidu MP, Port LR, Gay-Mimbrera J, Gómez-Arias PJ, Alkon N, Beaziz-Tordjman J, Estrada Y, Renert-Yuval Y, Ruano J, Guttman-Yassky E.

Transcriptomic profiling of vitiligo patients shows polar immune dysregulation in involved and uninvolved skin

J Allergy Clin Immunol. 2025 Jun.

DOI: 10.1016/j.jaci.2025.06.002

Guttman-Yassky E, Renert-Yuval Y, Brunner PM.

Atopic dermatitis

Lancet. 2025 Feb.

DOI: 10.1016/S0140-6736(24)02519-4

Meledathu S, Naidu MP, Brunner PM.

Update on atopic dermatitis

J Allergy Clin Immunol. 2025 Jan

DOI: 10.1016/j.jaci.2025.01.013

Bar J, Del Duca E, David E, Bose S, Chefitz G, Brunner PM, Bissonnette R, Guttman-Yassky E.

Skin Tape Stripping Reveals Distinct Biomarker Profiles in Chronic Hand Eczema of Patients With and Without Comorbid Atopic Dermatitis

Allergy. 2025 Jan

DOI: 10.1111/all.16466

Alkon N, Chennareddy S, Cohenour ER, Ruggiero JR, Stingl G, Bangert C, Rindler K, Bauer WM, Weninger W, Griss J, Jonak C, Brunner PM.

Single cell sequencing delineates T-cell clonality and pathogenesis of the parapsoriasis disease group

J Allergy Clin Immunol. 2025 Feb.

DOI: 10.1016/j.jaci.2024.09.004

Chennareddy S, Brunner PM.

From genes to geography: mapping allergic disease landscapes with spatial transcriptomics

J Allergy Clin Immunol. 2025 Mar.

DOI: 10.1016/j.jaci.2024.08.025

Chennareddy S, Rindler K, Ruggiero JR, Alkon N, Cohenour ER, Tran S, Weninger W, Griss J, Jonak C, Brunner PM.

Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes

Br J Dermatol. 2025 Jan

DOI: 10.1093/bjd/ljae313

Li R, Strobl J, Poyner EFM, Balbaa A, Torabi F, Mazin PV, Chipampe NJ, Stephenson E, Ramírez-Suástegi C, Shanmugiah VBM, Gardner L, Olabi B, Coulthard R, Botting RA, Zila N, Prigmore E, Gopee NH, Chroscik MA, Kritikaki E, Engelbert J, Goh I, Chan HM, Johnson HF, Ellis J, Rowe V, Tun W, Reynolds G, Yang D, Foster AR, Gambardella L, Winheim E, Admane C, Rumney B, Steele L, Jardine L, Nenonen J, Pickard K, Lumley J, Hampton P, Hu S, Liu F, Liu X, Horsfall D, Basurto-Lozada D, Grimble L, Bacon CM, Weatherhead SC, Brauner H, Wang Y, Bai F, Reynolds NJ, Allen JE, Jonak C, Brunner PM, Teichmann SA, Haniffa M.

Cutaneous T cell lymphoma atlas reveals malignant T_H2 cells supported by a B cell-rich tumor microenvironment

Nat Immunol. 2024 Nov

DOI: 10.1038/s41590-024-02018-1

Neubauer ZJK, Brunner PM, Geskin LJ, Guttman E, Lipner SR.

Decoupling the Association of Dupilumab with Cutaneous T-Cell Lymphoma

J Am Acad Dermatol. 2024

DOI: 10.1016/j.jaad.2024.08.057

Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, Konicek BW, Kadziola Z, Nunez M, Brnabic A, Schuster C.

Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)

Acta Derm Venereol. 2024 Sep

DOI: 10.2340/actadv.v104.40556

Bangert C, Alkon N, Chennareddy S, Arnoldner T, Levine JP, Pilz M, Medjimorec MA, Ruggiero J, Cohenour ER, Jonak C, Damsky W, Griss J, Brunner PM

Dupilumab-associated head and neck dermatitis shows a pronounced type 22 immune signature mediated by oligoclonally expanded T cells

Nat Commun. 2024 Apr

DOI: 10.1038/s41467-024-46540-0

Chang YT, Prompsy P, Kimeswenger S, Tsai YC, Ignatova D, Pavlova O, Iselin C, French LE, Levesque MP, Kuonen F, Bobrowicz M, Brunner PM, Pascolo S, Hoetzenecker W, Guenova E.

MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides

Nat Commun. 2024 Jan

DOI: 10.1038/s41467-024-45083-8

Brunner PM

A novel treatment approach for atopic dermatitis

Lancet. 2024 Aug

DOI: 10.1016/S0140-6736(24)01488-0

Tran SS, Ungar B, Brunner PM.

Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream

JAAD Case Rep. 2024 Mar

DOI: 10.1016/j.jdcr.2024.02.022